Pro: The Food and Drug Administration Black box warning on droperidol is not justified

Anesth Analg. 2008 May;106(5):1414-7. doi: 10.1213/ane.0b013e31816ba463.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiemetics / adverse effects*
  • Consumer Product Safety
  • Dose-Response Relationship, Drug
  • Droperidol / adverse effects*
  • Drug Approval*
  • Drug Labeling*
  • Drug Utilization
  • Evidence-Based Medicine
  • Heart Conduction System / drug effects*
  • Humans
  • Long QT Syndrome / chemically induced
  • Long QT Syndrome / physiopathology
  • Postoperative Nausea and Vomiting / prevention & control*
  • Torsades de Pointes / chemically induced
  • Torsades de Pointes / physiopathology
  • United States
  • United States Food and Drug Administration*

Substances

  • Antiemetics
  • Droperidol